These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 11424440)
1. [Effectiveness and cost-benefit of screening for gastric cancer in Japan]. Tsuji I; Tsubono Y; Hisamichi S Nihon Rinsho; 2001 Apr; 59 Suppl 4():533-7. PubMed ID: 11424440 [No Abstract] [Full Text] [Related]
2. Endoscopic screening for gastric cancer. Dan YY; So JB; Yeoh KG Clin Gastroenterol Hepatol; 2006 Jun; 4(6):709-16. PubMed ID: 16765306 [TBL] [Abstract][Full Text] [Related]
3. The impact of mass screening on gastric cancer mortality in Japan. Kawai K; Watanabe Y Gastrointest Endosc; 1998 Mar; 47(3):320-3. PubMed ID: 9540897 [No Abstract] [Full Text] [Related]
4. Effectiveness of gastric mass screening in Japan. Hisamichi S; Sugawara N; Fukao A Cancer Detect Prev; 1988; 11(3-6):323-9. PubMed ID: 3390854 [TBL] [Abstract][Full Text] [Related]
5. [Benefit-risk analysis for mass screening of stomach cancer in Japan. II. Genentic risk and cost of mass screening (author's transl)]. Iinuma TA; Tateno Y; Umegaki Y; Hashizume T; Kitabatake T Nihon Igaku Hoshasen Gakkai Zasshi; 1978 Jul; 38(7):625-32. PubMed ID: 704295 [No Abstract] [Full Text] [Related]
6. Declining cost-effectiveness of screening for disease. The case of gastric cancer in Japan. Babazono A; Hillman AL Int J Technol Assess Health Care; 1995; 11(2):354-64. PubMed ID: 7790176 [TBL] [Abstract][Full Text] [Related]
7. Outcomes of mass screening for gastric carcinoma. Kunisaki C; Ishino J; Nakajima S; Motohashi H; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H Ann Surg Oncol; 2006 Feb; 13(2):221-8. PubMed ID: 16411143 [TBL] [Abstract][Full Text] [Related]
8. Lower risk of death from gastric cancer among participants of gastric cancer screening in Japan: a population-based cohort study. Miyamoto A; Kuriyama S; Nishino Y; Tsubono Y; Nakaya N; Ohmori K; Kurashima K; Shibuya D; Tsuji I Prev Med; 2007 Jan; 44(1):12-9. PubMed ID: 16956654 [TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese. Xie F; Luo N; Blackhouse G; Goeree R; Lee HP Int J Technol Assess Health Care; 2008; 24(1):87-95. PubMed ID: 18218173 [TBL] [Abstract][Full Text] [Related]
10. [Cost-effectiveness analysis of breast cancer screening with mammography]. Iinuma T Nihon Rinsho; 2007 Jun; 65 Suppl 6():226-8. PubMed ID: 17682158 [No Abstract] [Full Text] [Related]
11. [Mass screening of gastric cancer--limits and prospects]. Yamaki G; Higashi K Gan To Kagaku Ryoho; 2002 Nov; 29(11):1883-7. PubMed ID: 12465385 [TBL] [Abstract][Full Text] [Related]
12. Gut check: can cost-effectiveness analysis help eliminate gastric cancer in Asia? Ramsey S Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):873-4. PubMed ID: 17507608 [No Abstract] [Full Text] [Related]
13. [Cost-effectiveness analysis of the mass screening of lung cancer]. Iinuma T; Tateno Y Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Nov; 48(11):1342-8. PubMed ID: 3148903 [No Abstract] [Full Text] [Related]
14. [The characteristics of stomach cancer diagnosed in mass screening]. Fujii A Gan No Rinsho; 1989 May; Spec No():10-6. PubMed ID: 2601008 [No Abstract] [Full Text] [Related]
15. Early gastric carcinoma diagnoses in Japan: radiologic, endoscopic, and pathologic alert. Rybak BJ Mt Sinai J Med; 1987 Jun; 54(5):413-6. PubMed ID: 2821392 [No Abstract] [Full Text] [Related]
16. [Problems associated with mass-screening system for gastric cancer in Japan]. Kikuchi S; Inaba Y Nihon Koshu Eisei Zasshi; 1992 Jul; 39(7):380-6. PubMed ID: 1504332 [TBL] [Abstract][Full Text] [Related]
17. [Cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: Markov decision analysis]. Wang Q; Jin PH; Lin GW; Xu SR; Chen J Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Feb; 24(2):135-9. PubMed ID: 12697117 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of coronary artery disease screening in asymptomatic patients with type 2 diabetes and other atherogenic risk factors in Japan: factors influencing on international application of evidence-based guidelines. Hayashino Y; Shimbo T; Tsujii S; Ishii H; Kondo H; Nakamura T; Nagata-Kobayashi S; Fukui T Int J Cardiol; 2007 May; 118(1):88-96. PubMed ID: 16949690 [TBL] [Abstract][Full Text] [Related]
19. Screening for gastric cancer in Japan. Kawai K Clin Gastroenterol; 1978 Sep; 7(3):605-22. PubMed ID: 101324 [No Abstract] [Full Text] [Related]
20. [A simple mathematical model for a quantitative evaluation of mass screening for detection of cancer]. Iinuma T; Tateno Y Gan No Rinsho; 1990 Nov; 36(14):2427-33. PubMed ID: 2250365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]